Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alessia De Nisco is active.

Publication


Featured researches published by Alessia De Nisco.


Epilepsia | 2011

Electrical and autonomic cardiac function in patients with Dravet syndrome

Angelica Bibiana Delogu; Antonella Spinelli; Domenica Battaglia; C. Dravet; Alessia De Nisco; A Saracino; Costantino Romagnoli; Gaetano Antonio Lanza; Filippo Crea

Dravet syndrome (DS) is an epileptic encephalopathy related mainly to mutations in the SCN1A gene, encoding for neuronal sodium channels. Patients with DS have a high risk of sudden unexpected death in epilepsy (SUDEP). In this study we investigated whether patients with DS present abnormalities in electrical and autonomic cardiac function. To this aim we assessed ventricular repolarization and heart rate variability (HRV) on standard electrocardiography (ECG) and on 24‐h ECG Holter monitoring, respectively, in 20 patients affected by DS (6.8 ± 4 years, 11 female). As age‐ and sex‐matched control groups, we also studied 20 patients with other epileptic syndromes receiving antiepileptic drugs (ES/AED, 6.0 ± 5 years, 12 female), 20 patients with other epileptic syndromes without treatment (ES/no‐AED, 6.7 ± 4 years, 10 female), and 20 healthy children (HC, 7.2 ± 5 years, 11 females). Data analysis showed that patients with DS had depressed HRV variables compared to both ES patients (ES/AED and ES/no‐AED) and HC control group, whereas no significant differences in HRV variables were found between ES patients (with and without treatment) and HC. There was no significant difference between patients with DS and all the other control groups in RR intervals, QT, and QTc interval analysis. In conclusion, DS patients display an imbalance of cardiac autonomic function toward a relative predominance of adrenergic tone compared to both healthy children and patients with other forms of epilepsy, independent of antiepileptic therapy. Follow‐up studies should clarify the clinical significance of this autonomic impairment and whether HRV analysis can be helpful in predicting the risk of sudden death in patients with DS.


BMJ Open | 2011

Effectiveness and safety of the A-H1N1 vaccine in children: A hospital-based case - Control study

Francesca Menniti-Ippolito; Roberto Da Cas; Luciano Sagliocca; Giuseppe Traversa; Fernanda Ferrazin; Carmela Santuccio; Loriana Tartaglia; Francesco Trotta; Pasquale Di Pietro; Salvatore Renna; Rossella Rossi; Bianca Domenichini; Stefania Gamba; Francesco Trovato; Pier-Angelo Tovo; Manuela Bianciotto; Carmelina Calitri; Clara Gabiano; Irene Raffaldi; Antonio Urbino; Liviana Da Dalt; Valentina Favero; Laura Giordano; Maura Baraldi; Federica Bertuola; Eleonora Lorenzon; Francesca Parata; Giorgio Perilongo; Silvia Vendramin; Monica Frassineti

Objective To verify whether vaccination against the A-H1N1 virus in the paediatric population was effective in preventing the occurrence of influenza-like illness (ILI) or was associated with adverse events of special interest. Design, setting and patients A case–control analysis was performed as part of surveillance of children hospitalised through the emergency departments of eight paediatric hospitals/wards for ILI, neurological disorders, non-infectious muco-cutaneous diseases and vasculitis, thrombocytopaenia and gastroduodenal lesions. Results Among 736 children enrolled from November 2009 to August 2010, only 25 had been vaccinated with the pandemic vaccine. Out of 268 children admitted for a diagnosis compatible with the adverse events of special interest, six had received the A-H1N1 vaccine, although none of the adverse events occurred within the predefined risk windows. Only 35 children out of 244 admitted with a diagnosis of ILI underwent laboratory testing: 11 were positive and 24 negative for the A-H1N1 virus. None of the A-H1N1 positive children had received the pandemic vaccine. The OR of ILI associated with any influenza vaccination was 0.9 (95% CI 0.1 to 5.5). Conclusions The study provides additional information on the benefit–risk profile of the pandemic vaccine. No sign of risk associated with the influenza A-H1N1 vaccine used in Italy was found, although several limitations were observed: in Italy, pandemic vaccination coverage was low, the epidemic was almost over by mid December 2009 and the A-H1N1 laboratory test was performed only during the epidemic phase (in <10% of children). This study supports the importance of the existing network of hospitals for the evaluation of signals relevant to new vaccines and drugs.


Pediatric Critical Care Medicine | 2011

Neurogenic stunned myocardium presenting as left ventricular hypertrabeculation in childhood: a variant of Takotsubo cardiomyopathy?

Gabriella De Rosa; Manuela Pardeo; Concezio Di Rocco; Domenico Pietrini; Sonia Mensi; Eleonora Stival; Alessia De Nisco; Laura Marzano; Daniele De Luca; Marco Piastra

Objective: To report the first case of neurogenic stunned myocardium presenting with heart left ventricle noncompaction requiring intensive care in the perioperative period of tension tumor-induced hydrocephalus. Methods and Design: Case report and literature review. Our Institutional Review Board waived the need for consent. Patient: A 12-yr-old female with intracranial astrocytoma and hypertensive hydrocephalus presented with severe heart dysfunction and life-threatening ventricular ectopies intraoperatively. A severe heart failure developed requiring hemodynamic and ventilatory support for 10 days. Echocardiography showed a transient noncompaction aspect of the left ventricular wall, further confirmed by a cardiac magnetic resonance image. The noncompaction aspect lasted until 15 days postadmission, as was the case for the QT interval prolongation; no life-threatening ectopies were demonstrated on the subsequent Holter electrocardiogram monitoring. Conclusions: This report describes a unique presentation of myocardial stunning in association with an intracranial illness, namely, a hypertensive hydrocephalus complicating an intracranial neoplasm.


Fetal Diagnosis and Therapy | 2011

Neonatal emergencies associated with cardiac rhabdomyomas: an 8-year experience.

Gabriella De Rosa; Maria Pia De Carolis; Manuela Pardeo; Iliana Bersani; Alessia Tempera; Alessia De Nisco; Leonardo Caforio; Costantino Romagnoli; Marco Piastra

During the foetal-neonatal period, rhabdomyomas represent the majority of cardiac tumours and are closely associated with tuberous sclerosis. Cardiac rhabdomyomas may be completely asymptomatic and are incidentally discovered during an echocardiogram, or may cause cardiac dysfunctions requiring medical and/or surgical intervention. During foetal life and the early neonatal period, life-threatening conditions, mostly due to arrhythmias, cardiac failure or obstruction, do occur on rare occasions. We reviewed the medical records of all cases of cardiac rhabdomyomas diagnosed prenatally or postnatally over an 8-year period. The present study reviews 7 cases of life-threatening conditions. Arrhythmic episodes were described in 5 patients, and blood flow obstruction was reported in 2 cases. Antiarrhythmic agents successfully controlled the clinical and electrophysiological conditions. Obstructive conditions were associated with poor outcomes. In conclusion, when prenatal diagnosis of rhabdomyoma is made, appropriate planning at delivery for the management of potential haemodynamic complications may prevent adverse neonatal outcomes. The clinical outcome is more influenced by obstructive rather than by dysrhythmic complications. Appropriate antiarrhythmic treatment is of primary importance. In all cases discovered through prenatal and/or neonatal life-threatening conditions, an accurate follow-up should always be performed to anticipate the development of tuberous sclerosis.


Rheumatology International | 2010

Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome.

Donato Rigante; Piero Valentini; Roberta Onesimo; Donatella Francesca Angelone; Alessia De Nisco; Giulia Bersani; Angelica Bibiana Delogu

A 3-month-old child was first treated for incomplete Kawasaki syndrome with three cycles of intravenous immunoglobulins and aspirin, then with methylprednisolone which led to fever remission. The same child was re-hospitalized after a 10-month-period of well-being for the suspicion of a new episode of Kawasaki syndrome, which appeared to be immunoglobulin-resistant: extensive testing failed to provide an alternative diagnosis of any infectious or infiltrative disease. Diagnosis of systemic onset-juvenile idiopathic arthritis was postulated upon the long persistence of fever and inflammatory signs, which subsided only after starting corticosteroid treatment.


Rheumatology International | 2012

Kawasaki syndrome and concurrent Coxsackie virus B3 infection

Donato Rigante; Luca Cantarini; Marco Piastra; Donatella Francesca Angelone; Piero Valentini; Manuela Pardeo; Danilo Buonsenso; Angelica Bibiana Delogu; Daniele Serranti; Alessia De Nisco; Adele Compagnone; Gabriella De Rosa

We describe two previously healthy children who were hospitalized in the same period in different departments of our University with clinical signs of Kawasaki syndrome, which were treated with intravenous immunoglobulins and acetylsalicylic acid: in both cases, Coxsackie virus infection was concurrently demonstrated by enzyme-linked immunosorbent assay, and complement fixation test identified antibodies to serotype B3. In the acute phase, both patients presented hyperechogenic coronary arteries, but no cardiologic sequels in the mid term. The etiological relationship between Kawasaki syndrome and Coxsackie viruses is only hypothetical; however, the eventual identification of ad hoc environmental triggers is advisable in front of children with Kawasaki syndrome, with the aim of optimizing epidemiological surveillance and understanding the intimate biological events of this condition.


European Heart Journal | 2011

Platelet reactivity and endothelial function in children of patients with early acute myocardial infarction

Gaetano Antonio Lanza; Giancarla Scalone; Lucy Barone; Fabio Infusino; Antonio Di Monaco; Angelica Bibiana Delogu; Irma Battipaglia; Alessia De Nisco; Alfonso Sestito; Costantino Romagnoli; Filippo Crea

AIMS To assess whether platelet reactivity is increased in offspring of patients with early acute myocardial infarction (AMI) and its possible relation with endothelial dysfunction. METHODS AND RESULTS We studied 23 healthy children (15±3 years, 13 males) of patients with early AMI (≤50 years old; Group 1) and 21 healthy children of healthy subjects without any history of cardiovascular disease (14±3 years, 10 males; Group 2). Platelet reactivity was assessed by flow cytometry as the increase in monocyte-platelet aggregates (MPA) and CD41 and PAC-1 platelet expression in response to exercise stress test (EST), adenosine diphosphate (ADP) stimulation (10(-7) M), or both. Endothelial function was assessed by measuring brachial artery dilation during post-ischaemic forearm hyperaemia [flow-mediated dilation (FMD)]. Both EST and ADP induced a higher percentage increase in platelet receptor expression in Group 1, compared with Group 2, with the most significant difference being shown for the response to the combined stimuli (e.g. MPA, 23.1±12 vs. 5.63±8%, P<0.001; platelet PAC-1, 57.7±47 vs. 13.2±7%, P<0.001). Compared with Group 2, Group 1 children showed lower FMD (10.7±3.1 vs. 8.0±2.9%, respectively; P=0.007). However, no significant association was found between FMD and platelet reactivity. CONCLUSION Our results show increased platelet reactivity in children of patients with early AMI; the finding was not significantly correlated with endothelial dysfunction, suggesting that other mechanisms are mainly involved in the enhanced platelet response to agonistic stimuli.


Rheumatology International | 2011

Exercise-induced rhabdomyolysis and transient loss of deambulation as outset of partial carnitine palmityl transferase II deficiency

Donato Rigante; Giulia Bersani; Adele Compagnone; Anna Zampetti; Alessia De Nisco; Emanuela Sacco; Raffaella Marrocco

We report the case of a 13-year-old boy with an abrupt onset of leg pain and muscle weakness, incapability of deambulation and a laboratory picture of exercise-induced acute rhabdomyolysis. Intravenous hyperhydration and forced diuresis were adopted to avoid renal complications. No evidence of articular or residual muscular damage was appreciated in the short-term. The recurrence of rhabdomyolysis required a muscular biopsy showing a disturbance of fatty acid β-oxidation pathway.


Journal of Aapos | 2010

Occipital porencephaly in a child with gyrate atrophy of the choroid and retina

Donato Rigante; Maria Cristina Savastano; Antonio Maria Leone; Benedetto Falsini; A. Baldascino; Ilaria La Torraca; D. Lepore; Alessia De Nisco; Emanuela Sacco; Angelo Maria Minnella

A 4-year-old girl was hospitalized for psychomotor delay, low vision, and horizontal nystagmus. She was found to have bilateral chorioretinal atrophic scars and 2 large occipital porencephalic cavities. High plasma ornithine levels led to the presumed diagnosis of gyrate atrophy of the choroid and retina. After 6 months of arginine-restricted diet and high-dose pyridoxine (300 mg/d), there was no change of plasma ornithine level or ocular findings. To our knowledge, this is the first report showing an association of porencephaly with gyrate atrophy of the choroid and retina.


Rheumatology International | 2010

Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome.

Donato Rigante; Piero Valentini; Daniela Rizzo; Andrea Leo; Gabriella De Rosa; Roberta Onesimo; Alessia De Nisco; Donatella Francesca Angelone; Adele Compagnone; Angelica Bibiana Delogu

Collaboration


Dive into the Alessia De Nisco's collaboration.

Top Co-Authors

Avatar

Angelica Bibiana Delogu

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Gabriella De Rosa

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Donato Rigante

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Gaetano Antonio Lanza

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Marco Piastra

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Manuela Pardeo

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Adele Compagnone

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Donatella Francesca Angelone

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Filippo Crea

Catholic University of the Sacred Heart

View shared research outputs
Top Co-Authors

Avatar

Piero Valentini

Catholic University of the Sacred Heart

View shared research outputs
Researchain Logo
Decentralizing Knowledge